Support teaching, research, and patient care.
Dr. Lin is a board-certified ophthalmologist and fellowship-trained cornea specialist, focusing on the medical and surgical management of cornea conditions, as well as cataract surgery. He has launched cutting edge surgical procedures at Stanford including ultra-thin DSAEK, DMEK and DALK at Stanford. He conducts clinical trials on cornea transplantation and ocular inflammation and infections. Dr. Lin sees patients at the Byers Eye Institute at Stanford University. If you wish to make an appointment, please call 650-723-6995 and ask to speak with Ruby Huang. Charles Lin, MD received his AB in Environmental Science and Public Policy from Harvard University, graduating summa cum laude. He attended medical school at the University of California, San Francisco, where he received his M.D. with honors. Following an internship in Internal Medicine at Cedars-Sinai Hospital, he completed his ophthalmology residency at the University of California, San Francisco. Upon graduation, he was awarded the Heed Fellowship, a prestigious national award for ophthalmologists entering a career in academic medicine. He received subspecialty Cornea, External Disease, and Refractive Surgery training at the F.I. Proctor Foundation and University of California, San Francisco, one of the premier fellowships in the country.He has extensive clinical and surgical experience in the following diseases:•Cataract including complex cataract surgery•Fuchs Dystrophy•Corneal edema•Keratoconus & Pellucid Marginal Degeneration•Herpetic keratitis•Cornea ulcers•Pterygium•Corneal Dystrophies•Corneal & Conjunctival tumors•Blepharitis & Dry Eye
Cornea & External Diseases
Dr. Lin conducts clinical trials focused on cornea transplantation, corneal edema, and cornea infections at Stanford. His research interests include improving the success and safety of cutting edge surgeries such as ultra-thin DSAEK, DMEK, DALK, and DSO. He is actively researching surgical therapies for corneal edema and Fuchs' Dystrophy. He is among a handful of cornea specialists nationwide with extensive experience using intraoperative OCT imaging to perform cornea transplants.
Zoster Eye Disease Study
This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of
suppressive valacyclovir for one year in immunocompetent study participants with an episode
of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis
due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
View full details
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly
intravenous infusion for 6 doses at up to 3 mg/kg.
Descemet Endothelial Thickness Comparison Trial
The purpose of this study is to compare visual acuity outcomes of two types of endothelial
keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2)
Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be
randomized to have DSAEK and the other half will have DMEK.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .